President and CEO of Seattle Genetics, Inc. (SGEN, Financial) Clay B Siegall sells 2,000 shares of SGEN on 02/01/2013 at an average price of $29.61 a share.
Seattle Genetics, Inc. has a market cap of $3.57 billion; its shares were traded at around $29.91 with and P/S ratio of 17.8. Seattle Genetics, Inc. had an annual average earning growth of 3.5% over the past 10 years. GuruFocus rated Seattle Genetics, Inc. the business predictability rank of 2-star.
For the complete insider trading history of SGEN, click here.
Seattle Genetics, Inc. has a market cap of $3.57 billion; its shares were traded at around $29.91 with and P/S ratio of 17.8. Seattle Genetics, Inc. had an annual average earning growth of 3.5% over the past 10 years. GuruFocus rated Seattle Genetics, Inc. the business predictability rank of 2-star.
CEO Recent Trades:
- President and CEO Clay B Siegall sold 2,000 shares of SGEN stock on 02/01/2013 at the average price of 29.61. Clay B Siegall owns at least 1,170,961 shares after this. The price of the stock has increased by 1.01% since.
- President and CEO Clay B Siegall sold 8,249 shares of SGEN stock on 01/04/2013 at the average price of 24.13. Clay B Siegall owns at least 1,170,961 shares after this. The price of the stock has increased by 23.95% since.
- President and CEO Clay B Siegall sold 8,250 shares of SGEN stock on 12/03/2012 at the average price of 25.19. Clay B Siegall owns at least 1,170,961 shares after this. The price of the stock has increased by 18.74% since.
- President and CEO Clay B Siegall sold 8,250 shares of SGEN stock on 11/01/2012 at the average price of 25.51. Clay B Siegall owns at least 1,170,961 shares after this. The price of the stock has increased by 17.25% since.
- President and CEO Clay B Siegall sold 8,250 shares of SGEN stock on 10/01/2012 at the average price of 26.59. Clay B Siegall owns at least 1,170,961 shares after this. The price of the stock has increased by 12.49% since.
CFO Recent Trades:
- CFO Todd E Simpson sold 95,000 shares of SGEN stock on 09/06/2012 at the average price of 28.5. Todd E Simpson owns at least 70,762 shares after this. The price of the stock has increased by 4.95% since.
- CFO Todd E Simpson sold 45,000 shares of SGEN stock on 08/27/2012 at the average price of 26.97. Todd E Simpson owns at least 70,762 shares after this. The price of the stock has increased by 10.9% since.
- CFO Todd E Simpson sold 40,000 shares of SGEN stock on 08/16/2012 at the average price of 25.97. Todd E Simpson owns at least 50,762 shares after this. The price of the stock has increased by 15.17% since.
Directors and Officers Recent Trades:
- Chief Medical Officer Thomas C Reynolds sold 7,290 shares of SGEN stock on 01/28/2013 at the average price of 30.09. Thomas C Reynolds owns at least 57,601 shares after this. The price of the stock has decreased by 0.6% since.
- Chief Medical Officer Thomas C Reynolds sold 125,079 shares of SGEN stock on 01/15/2013 at the average price of 28. Thomas C Reynolds owns at least 57,601 shares after this. The price of the stock has increased by 6.82% since.
- COO Eric Dobmeier sold 50,983 shares of SGEN stock on 01/04/2013 at the average price of 24.95. Eric Dobmeier owns at least 122,846 shares after this. The price of the stock has increased by 19.88% since.
- COO Eric Dobmeier sold 50,000 shares of SGEN stock on 12/17/2012 at the average price of 23.7. Eric Dobmeier owns at least 113,829 shares after this. The price of the stock has increased by 26.2% since.
- Chief Medical Officer Thomas C Reynolds sold 66,588 shares of SGEN stock on 12/10/2012 at the average price of 25.77. Thomas C Reynolds owns at least 57,601 shares after this. The price of the stock has increased by 16.07% since.
For the complete insider trading history of SGEN, click here.
